BIOMAT Database Logo BIOMAT Database Logo

2-Arylthiomorpholine derivatives as potent and selective monoamine oxidase B inhibitors. 2010

Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Department of Chemistry, Faculty of Sciences, University of Chile, Santiago, Chile. iturriag@uchile.cl

2-Arylthiomorpholine and 2-arylthiomorpholin-5-one derivatives, designed as rigid and/or non-basic phenylethylamine analogues, were evaluated as rat and human monoamine oxidase inhibitors. Molecular docking provided insight into the binding mode of these inhibitors and rationalized their different potencies. Making the phenylethylamine scaffold rigid by fixing the amine chain in an extended six-membered ring conformation increased MAO-B (but not MAO-A) inhibitory activity relative to the more flexible alpha-methylated derivative. The presence of a basic nitrogen atom is not a prerequisite in either MAO-A or MAO-B. The best K(i) values were in the 10(-8)M range, with selectivities towards human MAO-B exceeding 2000-fold.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008995 Monoamine Oxidase An enzyme that catalyzes the oxidative deamination of naturally occurring monoamines. It is a flavin-containing enzyme that is localized in mitochondrial membranes, whether in nerve terminals, the liver, or other organs. Monoamine oxidase is important in regulating the metabolic degradation of catecholamines and serotonin in neural or target tissues. Hepatic monoamine oxidase has a crucial defensive role in inactivating circulating monoamines or those, such as tyramine, that originate in the gut and are absorbed into the portal circulation. (From Goodman and Gilman's, The Pharmacological Basis of Therapeutics, 8th ed, p415) EC 1.4.3.4. Amine Oxidase (Flavin-Containing),MAO,MAO-A,MAO-B,Monoamine Oxidase A,Monoamine Oxidase B,Type A Monoamine Oxidase,Type B Monoamine Oxidase,Tyramine Oxidase,MAO A,MAO B,Oxidase, Monoamine,Oxidase, Tyramine
D008996 Monoamine Oxidase Inhibitors A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) MAO Inhibitor,MAO Inhibitors,Reversible Inhibitors of Monoamine Oxidase,Monoamine Oxidase Inhibitor,RIMA (Reversible Inhibitor of Monoamine Oxidase A),Reversible Inhibitor of Monoamine Oxidase,Inhibitor, MAO,Inhibitor, Monoamine Oxidase,Inhibitors, MAO,Inhibitors, Monoamine Oxidase
D009025 Morpholines Tetrahydro-1,4-Oxazines,Tetrahydro 1,4 Oxazines
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors.
November 2019, Bioorganic chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Selective and potent monoamine oxidase type B inhibitors: 2-substituted 5-aryltetrazole derivatives.
November 1995, Journal of medicinal chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
3-(E)-Styryl-2H-chromene derivatives as potent and selective monoamine oxidase B inhibitors.
April 2018, Bioorganic chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
New 2-Pyrazoline and Hydrazone Derivatives as Potent and Selective Monoamine Oxidase A Inhibitors.
February 2021, Journal of medicinal chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Sulfanylphthalonitrile analogues as selective and potent inhibitors of monoamine oxidase B.
December 2012, Bioorganic & medicinal chemistry letters,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
2-Azolylchromone Derivatives as Potent and Selective Inhibitors of Monoamine Oxidases A and B.
January 2016, Chemical & pharmaceutical bulletin,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Aliphatic propargylamines: potent, selective, irreversible monoamine oxidase B inhibitors.
October 1992, Journal of medicinal chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
(E)-3-Heteroarylidenechroman-4-ones as potent and selective monoamine oxidase-B inhibitors.
July 2016, European journal of medicinal chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors.
May 2016, European journal of medicinal chemistry,
Susan Lühr, and Marcelo Vilches-Herrera, and Angélica Fierro, and Rona R Ramsay, and Dale E Edmondson, and Miguel Reyes-Parada, and Bruce K Cassels, and Patricio Iturriaga-Vásquez
Synthesis of new 7-oxycoumarin derivatives as potent and selective monoamine oxidase A inhibitors.
December 2012, Journal of medicinal chemistry,
Copied contents to your clipboard!